Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Lebleu

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Biomedicines|October 23, 2021
Oligonucleotides-Based TherapeuticsBernard Lebleu
Current Pharmaceutical Design|November 13, 2012
Editorial: Cell penetrating peptides as delivery vectors for biomoleculesBernard Lebleu
Biomedicines|January 8, 2025
Feature Collection in Peptide Therapeutics: Current Applications and Future DirectionsBernard Lebleu
Advanced Drug Delivery Reviews|February 22, 2005
Tat peptide-mediated cellular delivery: back to basicsHilary Brooks, Bernard Lebleu, Eric Vivès
International Journal of Pharmaceutics|June 16, 2009
Challenges for nanotechnology in delivery imaging. PrefaceGillian Barratt, Didier Betbeder, Bernard Lebleu
Oligonucleotides|March 18, 2004
Oligonucleotide-based strategies to inhibit human hepatitis C virusCamille Martinand-Mari, Bernard Lebleu, Ian Robbins
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2015
In Vitro Assays to Assess Exon Skipping in Duchenne Muscular DystrophyPrisca Boisguerin, Liz O'Donovan, Michael J Gait, et al.
Methods in Enzymology|June 3, 2004
Cationic liposomes/lipids for oligonucleotide delivery: application to the inhibition of tumorigenicity of Kaposi's sarcoma by vascular endothelial growth factor antisense oligodeoxynucleotidesCarole Lavigne, Yanto Lunardi-Iskandar, Bernard Lebleu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2002
Antiviral pathway activation in chronic fatigue syndrome and acute infectionKenny De Meirleir, Robert J Suhadolnik, Bernard Lebleu, et al.
European Journal of Biochemistry|February 22, 2002
Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to TatMichelle Silhol, Mudit Tyagi, Mauro Giacca, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Biomedicines|October 23, 2021
Oligonucleotides-Based TherapeuticsBernard Lebleu
Current Pharmaceutical Design|November 13, 2012
Editorial: Cell penetrating peptides as delivery vectors for biomoleculesBernard Lebleu
Biomedicines|January 8, 2025
Feature Collection in Peptide Therapeutics: Current Applications and Future DirectionsBernard Lebleu
Advanced Drug Delivery Reviews|February 22, 2005
Tat peptide-mediated cellular delivery: back to basicsHilary Brooks, Bernard Lebleu, Eric Vivès
International Journal of Pharmaceutics|June 16, 2009
Challenges for nanotechnology in delivery imaging. PrefaceGillian Barratt, Didier Betbeder, Bernard Lebleu
Oligonucleotides|March 18, 2004
Oligonucleotide-based strategies to inhibit human hepatitis C virusCamille Martinand-Mari, Bernard Lebleu, Ian Robbins
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2015
In Vitro Assays to Assess Exon Skipping in Duchenne Muscular DystrophyPrisca Boisguerin, Liz O'Donovan, Michael J Gait, et al.
Methods in Enzymology|June 3, 2004
Cationic liposomes/lipids for oligonucleotide delivery: application to the inhibition of tumorigenicity of Kaposi's sarcoma by vascular endothelial growth factor antisense oligodeoxynucleotidesCarole Lavigne, Yanto Lunardi-Iskandar, Bernard Lebleu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2002
Antiviral pathway activation in chronic fatigue syndrome and acute infectionKenny De Meirleir, Robert J Suhadolnik, Bernard Lebleu, et al.
European Journal of Biochemistry|February 22, 2002
Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to TatMichelle Silhol, Mudit Tyagi, Mauro Giacca, et al.
Pageof 6